ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 206,547 | 201,576 | 176,842 | 128,622 | 76,322 |
| Cost of Goods | 63,154 | 73,024 | 79,032 | 48,780 | 12,692 |
| Gross Profit | 143,393 | 128,552 | 97,810 | 79,842 | 63,630 |
| Operating Expenses | 127,196 | 93,217 | 69,513 | 60,543 | 31,622 |
| Operating Income | 16,351 | 35,359 | 28,329 | 20,079 | 32,700 |
| Interest Expense | 12,966 | 14,758 | 12,035 | 11,327 | 11,008 |
| Other Income | -228 | -550 | 55 | -74 | 41 |
| Pre-tax Income | 3,157 | 20,051 | 16,349 | 8,678 | 21,733 |
| Income Tax | -2,937 | 4,557 | 17,425 | 4,744 | 6,358 |
| Net Income Continuous | 6,094 | 15,494 | -1,076 | 3,934 | 15,375 |
| Net Income | $6,094 | $15,494 | $-1,076 | $3,934 | $15,375 |
| EPS Basic Total Ops | 0.51 | 1.31 | -0.09 | 0.34 | 1.34 |
| EPS Basic Continuous Ops | 0.51 | 1.33 | -0.09 | 0.34 | 1.35 |
| EPS Diluted Total Ops | 0.50 | 1.30 | -0.09 | 0.34 | 1.32 |
| EPS Diluted Continuous Ops | 0.51 | 1.32 | -0.09 | 0.34 | 1.33 |
| EPS Diluted Before Non-Recurring Items | 4.46 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $60,963 | $69,101 | $56,257 | $42,422 | $39,600 |